Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Antikörper

RET Reaktivität: Human WB, ELISA, IF Wirt: Huhn Polyclonal unconjugated
Produktnummer ABIN1450227
  • Target Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
    Ret Proto-Oncogene (RET)
    Reaktivität
    • 162
    • 100
    • 81
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 186
    • 22
    • 1
    • 1
    • 1
    • 1
    Huhn
    Klonalität
    • 180
    • 32
    Polyklonal
    Konjugat
    • 89
    • 14
    • 10
    • 9
    • 9
    • 9
    • 9
    • 9
    • 9
    • 9
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 1
    Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert
    Applikation
    • 170
    • 81
    • 66
    • 65
    • 43
    • 28
    • 18
    • 15
    • 15
    • 10
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF)
    Spezifität
    The RET proto-oncogeneis a receptor tyrosine kinase for members of the glial cell line-derivedneurotrophic factor family of extracellular signalling molecules
    Produktmerkmale
    Mono- and polyclonal antibodies to human growth factors and neural growth factor receptors.
    Aufreinigung
    RET affinity purified
    Isotyp
    IgY
    Top Product
    Discover our top product RET Primärantikörper
  • Applikationshinweise
    Westernimmunoblotting, recommended dilution 1:5 000 to 1:10 000, ELISA: 1:80 000 to 1:120000, IF 1:250 to 1:500. Polyclonal antibody working titer has to be established practically for each particularantigen and assay format
    Kommentare

    Synonym: Proto-oncogene tyrosine-protein kinase receptorRet, Cadherin family member 12, Proto-oncogene c-Ret

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/ml
    Buffer
    Concentrated ammonium sulphate in PBS pH 7.4
    Handhabung
    As product is (NH4)2SO4 precipitate, mix well by pipetting or vortexing prior use
    Lagerung
    4 °C
    Informationen zur Lagerung
    This product is shipped in non-frozen liquid form in ambient conditions
  • Target
    Ret Proto-Oncogene (RET)
    Andere Bezeichnung
    RET (RET Produkte)
    Synonyme
    c-ret antikoerper, cret antikoerper, etID315074.13 antikoerper, ret1 antikoerper, wu:fd13h01 antikoerper, X-ret antikoerper, ret-A antikoerper, xret antikoerper, RET antikoerper, MTC1 antikoerper, CDHF12 antikoerper, CDHR16 antikoerper, HSCR1 antikoerper, MEN2A antikoerper, MEN2B antikoerper, PTC antikoerper, RET-ELE1 antikoerper, RET51 antikoerper, RET9 antikoerper, c-Ret antikoerper, ret proto-oncogene receptor tyrosine kinase antikoerper, ret proto-oncogene S homeolog antikoerper, ret proto-oncogene antikoerper, ret antikoerper, ret.S antikoerper, RET antikoerper, Ret antikoerper
    Hintergrund
    Recombinant His-tagged extracellular fragment of humanRET protein produced using CHO-based cell line. The extracellular fragment of hRET was expressed andsecreted to the cell culture supernatant. Protein was purified by Ni-affinitychromatography following gel-filtration from cell culture supernatant
    UniProt
    P07949
    Pathways
    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Kundenservice